MENU
XLO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Xilio Therapeutics (XLO) Earnings Date & Reports
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer... Show more
A.I. Advisor
published Earnings
XLO is expected to report earnings to rise 218.18% to -104 cents per share on November 12
Q3'26
Est.
$-1.05
Q2'26
Beat
by $0.25
Q1'26
Missed
by $0.51
Q4'25
Beat
by $0.88
Q3'25
Missed
by $0.06
The last earnings report on August 12 showed earnings per share of -33 cents, beating the estimate of -57 cents. With 500.00 shares outstanding, the current market capitalization sits at 52.84M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
76
Web
https://www.xiliotx.com